Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function

T cells engineered to express chimeric antigen receptors (CAR-T cells) have shown impressive clinical efficacy in the treatment of B cell malignancies. However, the development of CAR-T cell therapies for solid tumors is hampered by the lack of truly tumor-specific antigens and poor control over T c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nat Commun
Asıl Yazarlar: Salzer, Benjamin, Schueller, Christina M., Zajc, Charlotte U., Peters, Timo, Schoeber, Michael A., Kovacic, Boris, Buri, Michelle C., Lobner, Elisabeth, Dushek, Omer, Huppa, Johannes B., Obinger, Christian, Putz, Eva M., Holter, Wolfgang, Traxlmayr, Michael W., Lehner, Manfred
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7441178/
https://ncbi.nlm.nih.gov/pubmed/32820173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-17970-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller